CymaBay Therapeutics (CBAY) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$32.48

0.00 (0.00%)

(As of 04/1/2024)

Source

Source	Headline
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Given Average Recommendation of "Hold" by Brokerages americanbankingnews.com - April 11 at 3:02 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Coverage Initiated by Analysts at StockNews.com americanbankingnews.com - April 11 at 2:18 AM
	Vanguard Group Inc. Purchases 598,707 Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - April 6 at 4:14 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Earns Sell Rating from Analysts at StockNews.com marketbeat.com - April 3 at 2:12 AM
	Assenagon Asset Management S.A. Invests $17.63 Million in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - March 28 at 5:56 AM
	Gilead reduces 2024 earnings guidance after completing CymaBay takeover za.investing.com - March 22 at 12:04 PM
	Gilead Sciences Completes Acquisition Of CymaBay Therapeutics markets.businessinsider.com - March 22 at 12:04 PM
	Gilead Sciences Announces Completion of Acquisition of CymaBay businesswire.com - March 22 at 9:18 AM
	marketbeat.com - March 22 at 6:11 AM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Shares Sold by Deutsche Bank AG marketbeat.com - March 22 at 4:12 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Reaches New 52-Week High at $32.48 marketbeat.com - March 18 at 10:55 AM
	CBAY Jul 2024 34.000 call finance.yahoo.com - March 16 at 8:32 PM
	CBAY Apr 2024 31.000 put finance.yahoo.com - March 16 at 8:32 PM
	CBAY Oct 2024 33.000 call finance.yahoo.com - March 16 at 3:31 PM
	CBAY Oct 2024 29.000 put finance.yahoo.com - March 16 at 3:31 PM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Sees Significant Drop in Short Interest marketbeat.com - March 14 at 7:53 PM
	Investing in CymaBay Therapeutics (NASDAQ:CBAY) three years ago would have delivered you a 540% gain finance.yahoo.com - March 11 at 5:46 PM
	Glenmede Trust Co. NA Buys Shares of 37,894 CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - March 10 at 6:19 AM
	Seven Eight Capital LP Purchases Shares of 41,556 CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - March 9 at 6:59 AM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Position Lessened by Adage Capital Partners GP L.L.C. marketbeat.com - March 5 at 1:19 PM
	CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis globenewswire.com - March 4 at 8:00 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Sets New 1-Year High at $32.35 marketbeat.com - March 1 at 10:37 AM
	610,770 Shares in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Acquired by MPM Bioimpact LLC marketbeat.com - March 1 at 10:19 AM
	HC Wainwright Equities Analysts Lower Earnings Estimates for CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - March 1 at 8:45 AM
	Maintaining Hold on CymaBay Amid Gilead Acquisition Deal Closure markets.businessinsider.com - February 29 at 2:54 PM
	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of CymaBay Therapeutics, Inc. (CBAY) markets.businessinsider.com - February 29 at 2:54 PM
	CymaBay Therapeutics (NASDAQ:CBAY) Rating Reiterated by HC Wainwright marketbeat.com - February 29 at 9:29 AM
	CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY marketwatch.com - February 28 at 11:13 PM
	CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update globenewswire.com - February 28 at 4:45 PM
	Algert Global LLC Purchases New Shares in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - February 28 at 6:36 AM
	Monashee Investment Management LLC Acquires New Shares in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - February 25 at 10:54 AM
	CymaBay Therapeutics (CBAY) Price Target Increased by 12.84% to 31.37 msn.com - February 24 at 8:31 AM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Shares Purchased by Swiss National Bank marketbeat.com - February 23 at 4:26 AM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Stake Lessened by Deutsche Bank AG marketbeat.com - February 22 at 5:25 AM
	The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis finance.yahoo.com - February 21 at 9:38 PM
	The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis prnewswire.com - February 21 at 5:43 PM
	Leerink Partners Downgrades CymaBay Therapeutics (CBAY) msn.com - February 20 at 5:38 PM
	CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) globenewswire.com - February 20 at 4:05 PM
	ClariVest Asset Management LLC Sells 63,600 Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY) marketbeat.com - February 20 at 10:16 AM
	SVB Leerink Reaffirms Market Perform Rating for CymaBay Therapeutics (NASDAQ:CBAY) marketbeat.com - February 20 at 8:18 AM
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Shares Acquired by New York State Common Retirement Fund marketbeat.com - February 18 at 4:30 AM
	CYMABAY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CymaBay Therapeutics, Inc. - CBAY businesswire.com - February 16 at 1:58 PM
	FY2026 Earnings Forecast for CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Issued By HC Wainwright marketbeat.com - February 15 at 8:59 AM
	CBAY Jan 2026 37.000 call finance.yahoo.com - February 15 at 8:02 AM
	CBAY Feb 2024 33.000 call finance.yahoo.com - February 14 at 8:47 PM
	CBAY Jan 2025 8.000 put finance.yahoo.com - February 14 at 8:47 PM
	Analysts Offer Predictions for CymaBay Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:CBAY) marketbeat.com - February 14 at 9:10 AM
	Analysts see over 50% gains in these 2 mid-cap biotech stocks (CBAY) marketbeat.com - February 14 at 9:10 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Earns Market Perform Rating from Lifesci Capital marketbeat.com - February 14 at 8:50 AM
	CymaBay Therapeutics (NASDAQ:CBAY) Sees Strong Trading Volume marketbeat.com - February 13 at 12:36 PM

Get CymaBay Therapeutics News Delivered to You Automatically

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CBAY Media Mentions By Week

CBAY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CBAY
News Sentiment
▼
0.00

0.49
▲
Average
Medical
News Sentiment

CBAY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CBAY Articles
This Week
▼
0

4
▲
CBAY Articles
Average Week

Get CymaBay Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:CBAY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CymaBay Therapeutics (CBAY) News Today

CBAY Media Mentions By Week

CBAY Media Sentiment

CBAY News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info